Supplier · ABN 40002879996 · 2060
Novo Nordisk Pharmaceuticals Pty Ltd
$170m
total value of 1 contract published 2023-02-09 to 2023-02-09
Whole-of-life contract values as published on AusTender, including amendments. They are commitments, not payments. 1 of these contracts (100.0% of value) were awarded by limited tender.
By agency
| Agency | Contracts | Total value | Limited tender |
|---|---|---|---|
| National Blood Authority | 1 | $170m | 100.0% |
Contracts
Largest first.
| Contract | Agency | Method | Published | Term | Value |
|---|---|---|---|---|---|
| Imported Plasma and Recombinant Products CN3936165 |
National Blood Authority | limited tender | 2023-02-09 | 2023-01-01 to 2027-06-30 | $170m was $80m |
These records are as published by the agencies on AusTender. If something here is wrong, the agency that published the notice can correct it, and we will pick up the correction at the next load. Report a problem with this page.